Patent schemes, hostage government payers driving US drug spending - FiercePharma

FiercePharmaPatent schemes, hostage government payers driving US drug spendingFiercePharmaTime and time again, as reports of drug price hikes went viral, pharma and biotech representatives hit back with statements that drug development is expensive and their prices are justified. But a new study in the Journal of the American Medical ...